IRIS
TOMASSINI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.253
AS - Asia 2.669
EU - Europa 1.821
SA - Sud America 492
Continente sconosciuto - Info sul continente non disponibili 460
AF - Africa 69
OC - Oceania 16
Totale 11.780
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.028
SG - Singapore 1.469
IT - Italia 525
CN - Cina 476
BR - Brasile 388
RU - Federazione Russa 368
VN - Vietnam 295
IE - Irlanda 280
GB - Regno Unito 148
CA - Canada 107
DE - Germania 105
HK - Hong Kong 99
SE - Svezia 86
IN - India 74
LT - Lituania 67
BD - Bangladesh 60
AR - Argentina 37
FI - Finlandia 37
JP - Giappone 35
MX - Messico 32
ES - Italia 29
AT - Austria 24
FR - Francia 24
PL - Polonia 24
TR - Turchia 23
UA - Ucraina 23
KR - Corea 21
IQ - Iraq 20
ZA - Sudafrica 20
NL - Olanda 17
HN - Honduras 16
EC - Ecuador 15
AU - Australia 14
JM - Giamaica 14
VE - Venezuela 14
PK - Pakistan 13
CR - Costa Rica 12
ID - Indonesia 12
CO - Colombia 11
IL - Israele 11
GT - Guatemala 10
BE - Belgio 9
CH - Svizzera 9
CZ - Repubblica Ceca 9
IR - Iran 9
PY - Paraguay 9
CL - Cile 8
KE - Kenya 8
MA - Marocco 8
RO - Romania 7
SC - Seychelles 7
UZ - Uzbekistan 7
EE - Estonia 6
EG - Egitto 6
SA - Arabia Saudita 6
TT - Trinidad e Tobago 6
NI - Nicaragua 5
PA - Panama 5
PE - Perù 5
PR - Porto Rico 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
DZ - Algeria 4
JO - Giordania 4
KZ - Kazakistan 4
SV - El Salvador 4
BB - Barbados 3
MY - Malesia 3
OM - Oman 3
UY - Uruguay 3
AL - Albania 2
AZ - Azerbaigian 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
EU - Europa 2
GA - Gabon 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
MD - Moldavia 2
MK - Macedonia 2
MQ - Martinica 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AO - Angola 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
Totale 11.307
Salva come PNG Salva come JPEG
Città #
Singapore 1.154
Dallas 974
San Jose 757
Ashburn 431
Chandler 286
Dublin 275
Council Bluffs 239
Santa Clara 202
Beijing 153
Los Angeles 133
The Dalles 100
Hong Kong 95
Jacksonville 88
Ho Chi Minh City 87
Phoenix 82
Princeton 82
New York 74
Buffalo 68
St Louis 61
Vilnius 60
Hanoi 57
Rome 57
North Bergen 55
Columbus 53
Hefei 51
Orem 51
Tongling 48
Munich 44
Altamura 41
São Paulo 40
Carrboro 34
Chicago 34
Moscow 34
Dong Ket 33
Montreal 33
Tokyo 33
Washington 33
Redondo Beach 31
Wilmington 31
Denver 29
Nuremberg 29
Atlanta 28
Brooklyn 27
London 27
Milan 27
Houston 26
Pescara 24
Chennai 23
Seattle 22
San Francisco 21
Seoul 21
Warsaw 20
Agrolândia 19
Naples 19
Boston 18
Chieti 18
Haiphong 17
Mexico City 16
Ann Arbor 15
Da Nang 15
Helsinki 15
Toronto 15
Boardman 14
Kyle 14
Mumbai 14
Romola 14
Stockholm 14
Teramo 14
Johannesburg 13
Lappeenranta 13
Falls Church 12
Frankfurt am Main 11
League City 11
Camerino 10
Kimball 10
San José 10
Brasília 9
Brussels 9
Campinas 9
Florence 9
Kingston 9
Manchester 9
New Delhi 9
Newark 9
Philadelphia 9
Rio de Janeiro 9
Baghdad 8
Fairfield 8
Memphis 8
Osimo 8
Silver Spring 8
Southend 8
Tehran 8
Vienna 8
Biên Hòa 7
Bologna 7
Castignano 7
Charlotte 7
Istanbul 7
Orlando 7
Totale 7.055
Salva come PNG Salva come JPEG
Nome #
Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis 368
Guillain−Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’ 218
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 180
Breath-hold BOLD fMRI without CO2 sampling enables estimation of venous cerebral blood volume: potential use in normalization of stimulus-evoked BOLD fMRI data 177
A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI 175
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 169
Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation 165
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases 154
Assessment of the Effects of Aerobic Fitness on Cerebrovascular Function in Young Adults Using Multiple Inversion Time Arterial Spin Labeling MRI 153
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 153
Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis 152
Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis 151
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta 151
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 148
Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging 144
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 144
Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivity 143
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients with Multiple Sclerosis 142
Brain morphometry in Multiple Sclerosis 141
Modelling the natural history of primary progressive multiple sclerosis 139
FACS-Proteomics strategy toward extracellular vesicles single-phenotype characterization in biological fluids: exploring the role of leukocyte-derived EVs in multiple sclerosis 137
Tractography in the presence of multiple sclerosis lesions 132
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS 129
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 128
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. 127
A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO 2) 127
Age-related changes in grey and white matter structure throughout adulthood 124
Neurological update: MOG antibody disease 123
Neuroplasticity and motor rehabilitation in multiple sclerosis 122
Lessons from immunotherapies in multiple sclerosis 121
How common is truly benign MS in a UK population? 120
Cerebral Metabolic Changes During Visuomotor Adaptation Assessed Using Quantitative fMRI 120
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis 119
Neurovascular Coupling During Visual Stimulation in Multiple Sclerosis: A MEG-fMRI Study 118
"Back to Braak": Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression 114
Medical education and MS: getting the training right 113
Oral contraceptives combined with interferon b in multiple sclerosis 113
Investigating social cognition in Multiple Sclerosis: Does Implicit Biological Motion processing affect visuo-spatial attention? 111
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment 110
A tractometry principal component analysis of white matter tract network structure and relationships with cognitive function in relapsing-remitting multiple sclerosis 105
Informing MS patients on treatment options: a consensus on the process of consent taking 105
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 105
Predicting the profile of increasing disability in multiple sclerosis 104
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 104
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial 103
Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis 102
Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model 101
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple Sclerosis 99
The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis 98
Alexithymia in multiple sclerosis: relationship with fatigue and depression 98
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 98
Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity 97
Site-specific clinical disease onset in multiple sclerosis 97
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 97
Similarities and differences between multiple sclerosis and type 1 diabetes 97
Model-free characterization of brain functional networks for motor sequence learning using fMRI 96
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 96
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 95
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression 94
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations 94
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis 93
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis 93
Relating brain damage to brain plasticity in patients with multiple sclerosis 93
Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge 93
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability 92
Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis 91
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis 91
Exploring the contribution of gray matter microstructure to R1 contrast via multi-compartment diffusion modelling in the healthy brain 90
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 90
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations 87
Neuroplasticity and functional recovery in multiple sclerosis 87
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial 85
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study 85
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 85
Changes in brain perfusion with training-related visuomotor improvement in MS 85
'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence 84
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis 84
Diagnosis and management of multiple sclerosis: MRI in clinical practice 84
Corrigendum: A Frequency-Domain Machine Learning Method for Dual-Calibrated fMRI Mapping of Oxygen Extraction Fraction (OEF) and Cerebral Metabolic Rate of Oxygen Consumption (CMRO 2) 84
Motor practice promotes increased activity in brain regions structurally disconnected after subcortical stroke 83
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis 83
Preservation of motor skill learning in patients with multiple sclerosis 82
Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study 80
Structural and functional bases for individual differences in motor learning 79
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis 78
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 77
Diffusion-Weighted Imaging Tractography-Based Parcellation of the Human Parietal Cortex and Comparison with Human and Macaque Resting-State Functional Connectivity 77
Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience 77
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study 77
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence 73
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study 73
Sex hormones, brain damage and clinical course of Multiple Sclerosis 71
Multiple sclerosis lesions: insights from imaging techniques 71
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 69
Contemporary study of multiple sclerosis disability in South East Wales 68
Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI 67
Transverse myelitis in children and adults 64
Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years 61
Sex hormones: a role in the control of multiple sclerosis? 60
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 56
Totale 10.962
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.804
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.804
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022201 0 0 0 0 8 12 3 37 25 5 17 94
2022/2023889 76 131 41 85 70 143 57 62 100 42 46 36
2023/2024640 52 21 55 24 32 184 116 41 15 33 14 53
2024/20252.205 120 544 421 52 47 58 76 82 192 147 161 305
2025/20265.074 334 224 1.141 528 345 187 596 320 529 438 295 137
2026/20272.325 189 333 404 1.133 266 0 0 0 0 0 0 0
Totale 11.780